These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32412788)

  • 21. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
    Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 23. Panic prescribing has become omnipresent during the COVID-19 pandemic.
    Caplan AL; Upshur R
    J Clin Invest; 2020 Jun; 130(6):2752-2753. PubMed ID: 32330122
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
    Abbasi J
    JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of TLR7 and Innate Immunity as an Efficient Method Against COVID-19 Pandemic: Imiquimod as a Potential Therapy.
    Poulas K; Farsalinos K; Zanidis C
    Front Immunol; 2020; 11():1373. PubMed ID: 32612613
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug repurposing in the era of COVID-19: a call for leadership and government investment.
    Martin JH; Bowden NA
    Med J Aust; 2020 Jun; 212(10):450-452.e1. PubMed ID: 32372435
    [No Abstract]   [Full Text] [Related]  

  • 27. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
    Cao Z; Wu Y; Faucon E; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
    [No Abstract]   [Full Text] [Related]  

  • 28. May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection?
    Shahmohamadnejad S; Nabavi SF; Habtemariam S; Sarkar K; Sil PC; Dowran R; Nabavi SM
    Cell Biol Int; 2020 Sep; 44(9):1770-1772. PubMed ID: 32449802
    [No Abstract]   [Full Text] [Related]  

  • 29. Existing Drugs Might Treat COVID-19.
    Abbasi J
    JAMA; 2020 Jun; 323(22):2239. PubMed ID: 32515802
    [No Abstract]   [Full Text] [Related]  

  • 30. Compensation of ACE2 Function for Possible Clinical Management of 2019-nCoV-Induced Acute Lung Injury.
    Wu Y
    Virol Sin; 2020 Jun; 35(3):256-258. PubMed ID: 32034638
    [No Abstract]   [Full Text] [Related]  

  • 31. The Landscape of Human Cancer Proteins Targeted by SARS-CoV-2.
    Tutuncuoglu B; Cakir M; Batra J; Bouhaddou M; Eckhardt M; Gordon DE; Krogan NJ
    Cancer Discov; 2020 Jul; 10(7):916-921. PubMed ID: 32444466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol and COVID-19: A Potential Role in Reducing Infectivity and Infection Severity of SARS-CoV-2.
    Skayem C; Ayoub N
    Am J Med Sci; 2020 Sep; 360(3):300. PubMed ID: 32631576
    [No Abstract]   [Full Text] [Related]  

  • 33. Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?
    Grimm C; Tang R
    Cell Calcium; 2020 Jun; 88():102212. PubMed ID: 32402856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series.
    Zangrillo A; Landoni G; Beretta L; Morselli F; Serpa Neto A; Bellomo R;
    Crit Care; 2020 May; 24(1):227. PubMed ID: 32414393
    [No Abstract]   [Full Text] [Related]  

  • 35. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetylcysteine as a potential treatment for COVID-19.
    Jorge-Aarón RM; Rosa-Ester MP
    Future Microbiol; 2020 Jul; 15():959-962. PubMed ID: 32662664
    [No Abstract]   [Full Text] [Related]  

  • 37. α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19.
    Williams SJ; Goddard-Borger ED
    Biochem Soc Trans; 2020 Jun; 48(3):1287-1295. PubMed ID: 32510142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review).
    Nitulescu GM; Paunescu H; Moschos SA; Petrakis D; Nitulescu G; Ion GND; Spandidos DA; Nikolouzakis TK; Drakoulis N; Tsatsakis A
    Int J Mol Med; 2020 Aug; 46(2):467-488. PubMed ID: 32468014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing old drugs as antiviral agents for coronaviruses.
    Yang CW; Peng TT; Hsu HY; Lee YZ; Wu SH; Lin WH; Ke YY; Hsu TA; Yeh TK; Huang WZ; Lin JH; Sytwu HK; Chen CT; Lee SJ
    Biomed J; 2020 Aug; 43(4):368-374. PubMed ID: 32563698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CNS penetration of potential anti-COVID-19 drugs.
    Richardson PJ; Ottaviani S; Prelle A; Stebbing J; Casalini G; Corbellino M
    J Neurol; 2020 Jul; 267(7):1880-1882. PubMed ID: 32361836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.